{"entity":{"type":"insider","cik":"0001665668","url":"/insider/0001665668","json_url":"/insider/0001665668.json","name":"THL Executive Fund VII, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":8,"first":"2018-08-13","last":"2021-06-09","span_basis":"filed_date"},"name_variants":[{"name":"THL Executive Fund VII, L.P.","source":"filing","n_filings":8,"first_seen":"2018-08-13","last_seen":"2021-06-09"}],"transactions":[{"id":5150394,"accession":"0001140361-21-020396","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-21-020396","line_url":"/filing/0001140361-21-020396","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"THL Equity Fund VII Investors (inVentiv), L.P.; THL Executive Fund VII, L.P.; THL Fund VII Coinvestment Partners, L.P.; THOMAS H. LEE ADVISORS, LLC","owner_display_name":"THL Equity Fund VII Investors (inVentiv), L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5044187.0,"shares_display":"5,044,187","price_per_share":81.2,"price_display":"81.20","price_state":"stated","total_value":409587984.4,"total_display":"409,587,984.40","total_whole":"409,587,984","shares_owned_after":391991.0,"shares_owned_after_display":"391,991","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-09","scope":"insider","n_lines":6},{"id":9233586,"accession":"0001140361-21-018266","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-21-018266","line_url":"/filing/0001140361-21-018266","is_derivative":false,"issuer_cik":"0001713160","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001713160","owner_cik":null,"owner_name":"THL Equity Fund VII Investors (inVentiv), L.P.; THL Executive Fund VII, L.P.; THL Fund VII Coinvestment Partners, L.P.; THOMAS H. LEE ADVISORS, LLC","owner_display_name":"THL Equity Fund VII Investors (inVentiv), L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":379878.0,"shares_display":"379,878","price_per_share":81.04,"price_display":"81.04","price_state":"stated","total_value":30785313.12,"total_display":"30,785,313.12","total_whole":"30,785,313","shares_owned_after":852.0,"shares_owned_after_display":"852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-20","scope":"insider","n_lines":3},{"id":4412737,"accession":"0001140361-21-017953","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-21-017953","line_url":"/filing/0001140361-21-017953","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"THL Equity Fund VII Investors (inVentiv), L.P.; THL Executive Fund VII, L.P.; THL Fund VII Coinvestment Partners, L.P.; THOMAS H. LEE ADVISORS, LLC","owner_display_name":"THL Equity Fund VII Investors (inVentiv), L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":379878.0,"shares_display":"379,878","price_per_share":81.04,"price_display":"81.04","price_state":"stated","total_value":30785313.12,"total_display":"30,785,313.12","total_whole":"30,785,313","shares_owned_after":5208835.0,"shares_owned_after_display":"5,208,835","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-18","scope":"insider","n_lines":3},{"id":4172717,"accession":"0001140361-21-016731","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-21-016731","line_url":"/filing/0001140361-21-016731","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"THL Equity Fund VII Investors (inVentiv), L.P.; THL Executive Fund VII, L.P.; THL Fund VII Coinvestment Partners, L.P.; THOMAS H. LEE ADVISORS, LLC","owner_display_name":"THL Equity Fund VII Investors (inVentiv), L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3391682.0,"shares_display":"3,391,682","price_per_share":81.04,"price_display":"81.04","price_state":"stated","total_value":274861909.28,"total_display":"274,861,909.28","total_whole":"274,861,909","shares_owned_after":5899055.0,"shares_owned_after_display":"5,899,055","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-06","filed_date":"2021-05-10","scope":"insider","n_lines":6},{"id":4962864,"accession":"0001140361-21-007502","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-21-007502","line_url":"/filing/0001140361-21-007502","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"THL Equity Fund VII Investors (inVentiv), L.P.; THL Executive Fund VII, L.P.; THL Fund VII Coinvestment Partners, L.P.; THOMAS H. LEE ADVISORS, LLC","owner_display_name":"THL Equity Fund VII Investors (inVentiv), L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3995954.0,"shares_display":"3,995,954","price_per_share":74.175,"price_display":"74.18","price_state":"stated","total_value":296399887.95,"total_display":"296,399,887.95","total_whole":"296,399,888","shares_owned_after":9517640.0,"shares_owned_after_display":"9,517,640","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-05","scope":"insider","n_lines":6},{"id":2353998,"accession":"0001140361-20-027523","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-20-027523","line_url":"/filing/0001140361-20-027523","is_derivative":false,"issuer_cik":"0001260937","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001260937","owner_cik":null,"owner_name":"ABBRECHT TODD M; Nelson Joshua M; THL Equity Fund VII Investors (inVentiv), L.P.; THL Executive Fund VII, L.P.; THL Fund VII Coinvestment Partners, L.P.; THOMAS H. LEE ADVISORS, LLC","owner_display_name":"ABBRECHT TODD M","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2771759.0,"shares_display":"2,771,759","price_per_share":61.28,"price_display":"61.28","price_state":"stated","total_value":169853391.52,"total_display":"169,853,391.52","total_whole":"169,853,392","shares_owned_after":13235545.0,"shares_owned_after_display":"13,235,545","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-03","filed_date":"2020-12-07","scope":"insider","n_lines":3},{"id":3336362,"accession":"0001140361-20-021029","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-20-021029","line_url":"/filing/0001140361-20-021029","is_derivative":false,"issuer_cik":"0001260937","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001260937","owner_cik":null,"owner_name":"ABBRECHT TODD M; Nelson Joshua M; THL Equity Fund VII Investors (inVentiv), L.P.; THL Executive Fund VII, L.P.; THL Fund VII Coinvestment Partners, L.P.; THOMAS H. LEE ADVISORS, LLC","owner_display_name":"ABBRECHT TODD M","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3233719.0,"shares_display":"3,233,719","price_per_share":59.26,"price_display":"59.26","price_state":"stated","total_value":191630187.94,"total_display":"191,630,187.94","total_whole":"191,630,188","shares_owned_after":16006677.0,"shares_owned_after_display":"16,006,677","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-17","filed_date":"2020-09-21","scope":"insider","n_lines":3},{"id":6749272,"accession":"0001140361-18-036241","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-036241","line_url":"/filing/0001140361-18-036241#line-1","is_derivative":false,"issuer_cik":"0001260943","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001260943","owner_cik":null,"owner_name":"Great-West Investors LP; Putnam Investments Employees' Securities Co III LLC; THL Coinvestment Partners, L.P.; THL Equity Fund VII Investors (inVentiv), L.P.; THL Executive Fund VII, L.P.; THL Fund VII Coinvestment Partners, L.P.; THL Operating Partners, L.P.; THOMAS H. LEE ADVISORS, LLC","owner_display_name":"Great-West Investors LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000000.0,"shares_display":"6,000,000","price_per_share":49.73,"price_display":"49.73","price_state":"stated","total_value":298380000.0,"total_display":"298,380,000.00","total_whole":"298,380,000","shares_owned_after":19239664.0,"shares_owned_after_display":"19,239,664","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-09","filed_date":"2018-08-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001610950","name":"Syneos Health, Inc.","url":"/issuer/0001610950","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2018-08-13","last_seen":"2021-06-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001665668","retrieved_at":"2026-08-22T07:27:22+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}